A. Barrett, Yellow Fever in Angola and Beyond ??? The Problem of Vaccine Supply and Demand, New England Journal of Medicine, vol.375, issue.4, pp.301-303, 2016.
DOI : 10.1056/NEJMp1606997

T. Monath and P. Vasconcelos, Yellow fever, Journal of Clinical Virology, vol.64, pp.160-173, 2015.
DOI : 10.1016/j.jcv.2014.08.030

J. Frierson, The yellow fever vaccine: a history, Yale J Biol Med, vol.83, pp.77-85, 2010.

E. Gotuzzo, S. Yactayo, and E. Córdova, Efficacy and Duration of Immunity after Yellow Fever Vaccination: Systematic Review on the Need for a Booster Every 10 Years, The American Journal of Tropical Medicine and Hygiene, vol.89, issue.3, pp.434-444, 2013.
DOI : 10.4269/ajtmh.13-0264

R. De-menezes-martins, F. Leal, M. Da, L. Homma, and A. , Serious adverse events associated with yellow fever vaccine, Human Vaccines & Immunotherapeutics, vol.24, issue.2, pp.2183-2187, 2015.
DOI : 10.1016/j.vaccine.2005.12.052

R. Tanizaki, M. Ujiie, N. Hori, S. Kanagawa, S. Kutsuna et al., Comparative study of adverse events after yellow fever vaccination between elderly and non-elderly travellers: questionnaire survey in Japan over a 1-year period, Journal of Travel Medicine, vol.23, issue.3, 2016.
DOI : 10.1093/jtm/taw012

A. Fisker, H. Ravn, A. Rodrigues, M. Østergaard, C. Bale et al., Co-administration of live measles and yellow fever vaccines and inactivated pentavalent vaccines is associated with increased mortality compared with measles and yellow fever vaccines only. An observational study from Guinea-Bissau, Vaccine, vol.32, issue.5, pp.598-605, 2014.
DOI : 10.1016/j.vaccine.2013.11.074

T. Monath, J. Woodall, D. Gubler, T. Yuill, J. Mackenzie et al., Yellow fever vaccine supply: a possible solution, The Lancet, vol.387, issue.10028, pp.1599-1600, 2016.
DOI : 10.1016/S0140-6736(16)30195-7

T. Monath, E. Fowler, C. Johnson, J. Balser, M. Morin et al., An Inactivated Cell-Culture Vaccine against Yellow Fever, New England Journal of Medicine, vol.364, issue.14, pp.1326-1333, 2011.
DOI : 10.1056/NEJMoa1009303

J. Julander, D. Trent, and T. Monath, Immune correlates of protection against yellow fever determined by passive immunization and challenge in the hamster model, Vaccine, vol.29, issue.35, pp.6008-6016, 2011.
DOI : 10.1016/j.vaccine.2011.06.034

S. Spector and N. Tauraso, Yellow fever virus. I. Development and evaluation of a plaque neutralization test, Appl Microbiol, vol.16, pp.1770-1775, 1968.

E. Jonker, L. Visser, and A. Roukens, Advances and controversies in yellow fever vaccination, Therapeutic Advances in Vaccines, vol.29, issue.136, pp.144-152, 2013.
DOI : 10.1007/s10875-008-9267-3
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991151

R. Mason, N. Tauraso, R. Spertzel, and R. Ginn, Yellow fever vaccine: direct challenge of monkeys given graded doses of 17D vaccine, Appl Microbiol, vol.25, pp.539-544, 1973.

M. Hepburn, M. Kortepeter, P. Pittman, E. Boudreau, J. Mangiafico et al., Neutralizing antibody response to booster vaccination with the 17d yellow fever vaccine, Vaccine, vol.24, issue.15, pp.2843-2849, 2006.
DOI : 10.1016/j.vaccine.2005.12.055
URL : http://www.dtic.mil/get-tr-doc/pdf?AD=ADA444709

M. Simões, L. Camacho, A. Yamamura, E. Miranda, A. Cajaraville et al., Evaluation of accuracy and reliability of the plaque reduction neutralization test (micro-PRNT) in detection of yellow fever virus antibodies, Biologicals, vol.40, issue.6, pp.399-404, 2012.
DOI : 10.1016/j.biologicals.2012.09.005

M. Salmona, S. Gazaigne, S. Mercier-delarue, F. Garnier, J. Korimbocus et al., Molecular characterization of the 17D-204 yellow fever vaccine, Vaccine, vol.33, issue.41, pp.5432-5436, 2015.
DOI : 10.1016/j.vaccine.2015.08.055

M. Fernandez-garcia, L. Meertens, M. Chazal, M. Hafirassou, O. Dejarnac et al., ABSTRACT, mBio, vol.7, issue.1, pp.1956-01915, 2016.
DOI : 10.1128/mBio.01956-15

C. Rice, A. Grakoui, R. Galler, and T. Chambers, Transcription of infectious yellow fever RNA from fulllength cDNA templates produced by in vitro ligation, New Biol, vol.1, pp.285-296, 1989.

T. Pierson, M. Diamond, A. Ahmed, L. Valentine, C. Davis et al., An infectious West Nile Virus that expresses a GFP reporter gene, Virology, vol.334, issue.1, pp.28-40, 2005.
DOI : 10.1016/j.virol.2005.01.021
URL : http://doi.org/10.1016/j.virol.2005.01.021

S. Mather, S. Scott, N. Temperton, E. Wright, B. King et al., Current progress with serological assays for exotic emerging/re-emerging viruses, Future Virology, vol.17, issue.8, pp.745-755, 2013.
DOI : 10.1128/JVI.75.6.2653-2659.2001